Pharmacogenomics
Subtitle: social, ethical, and clinical dimensions
By: edited by Mark A. Rothstein.
Contributors: Rothstein, Mark A.
Publisher: Wiley-Liss
Published: 2003
Place of publication: Hoboken, N.J
Language: eng
Number of pages: 368
Subjects: Pharmacogenomics.; Pharmacogenetics.; Drug Design.; Ethics, Medical.; Legislation, Medical.; Public Policy.; Social Environment.
Notes: Includes bibliographical references and index.
Table of contents: title: Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung; title: Pharmacogenomics: pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser; title: The implications of population genetics for pharmacogenomics / Craig L. Hanis; title: Genome research and minorities / Henry T. Greely; title: Drug development strategies / Penelope K. Manasco and Teresa E. Arledge; title: Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman; title: Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen; title: Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky; title: Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman; title: Medical liability for pharmacogenomics; title: Larry I. Palmer; title: The challenges of pharmacogenomics for pharmacy education / David B. Brushwood; title: Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson; title: Pharmacogenomics and the social construction of identity / Morris W. Foster; title: Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson; title: Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson.